Results 51 to 60 of about 6,115 (159)

Impact of timing on mucosal healing during restaging endoscopy in pediatric Crohn's disease: A retrospective cohort study

JPGN Reports, Volume 7, Issue 1, Page 99-106, February 2026.
Abstract While endoscopic remission is an important target in pediatric Crohn's disease (CD), no consensus for restaging timing exists. This retrospective cohort study assessed the timing and impact of restaging endoscopy in children with new CD in remission, comparing earlier ( ≤ 9 months) versus later endoscopy.
Anna Janecek, Alexandra S. Hudson, David L. Suskind, Hengqi B. Zheng, Samuel Simpson, Dale Lee, Ghassan Wahbeh, Hannibal Person   +7 more
wiley   +1 more source

Determination of Mesalamine Related Impurities from Drug Product by Reversed Phase Validated UPLC Method

E-Journal of Chemistry, 2011
In the present study gradient reversed-phase UPLC method was developed for simultaneous determination and separation of impurities and degradation products from drug product.
Trivedi Rakshit Kanubhai, Patel Mukesh C, Kharkar Amit R   +2 more
doaj   +1 more source

Simple and sensitive spectrophotometric methods for the analysis of mesalamine in bulk and tablet dosage forms

Química Nova, 2011
Three simple, sensitive, economical and reproducible spectrophotometric methods (A, B and C) are described for determination of mesalamine in pure drug as well as in tablet dosage forms. Method A is based on the reduction of tungstate and/or molybdate in
Bala Sekaran Chandra, Siva Santhosh Bhogela, Manjusha Shaik, Chaitanya Sravanthi Vadlamudi, Meghana Chappa, Naga Sirisha Maddirala   +5 more
doaj   +1 more source

Concurrent Presentation of von Willebrand Disease and Inflammatory Bowel Disease—A Case Report and Literature Review

eJHaem, Volume 7, Issue 2, April 2026.
Suraj Pratap, Aimee Foord
wiley   +1 more source

Patients' Experiences at the Inflammatory Bowel Disease Outpatient Clinic During the Pandemic—Healthcare Service Offer and Apprehension of Consequences of COVID‐19

JCC Plus, Volume 1, Issue 1, January 2026.
ABSTRACT Aim The COVID‐19 pandemic caused substantial changes in the routine management of patients with inflammatory bowel disease (IBD). The aim of this study was to survey the experience and the concerns of patients at the IBD outpatient clinic two years after the beginning of the pandemic.
Benoit Follin‐Arbelet, Kristian Marling Moum, Bjørn Moum   +2 more
wiley   +1 more source

Mesalamine induced hepatotoxicity. Is mesalamine safe?

Revista Española de Enfermedades Digestivas
Dear Editor: Mesalamine is a medication used widely in the treatment of patients with inflammatory bowel disease. Although mesalamine is considered safe, hepatotoxicity has been reported with an incidence of 0-4%. We present the clinical picture of a patient with hepatotoxicity due to mesalamine.
Javier, Pérez-Valenzuela, Lorena, Castro Solari, Rodrigo, Quera, Luis, Contreras   +3 more
openaire   +2 more sources

From Kitchen to Inflammatory Bowel Disease (IBD) Clinic: Transforming the Role of Dietitians in IBD Care. A Narrative Review by Dietitians With Expertise in IBD

JCC Plus, Volume 1, Issue 1, January 2026.
Dietitians' role in inflammatory bowel disease (IBD) has expanded from supportive care to five pillars of specialised nutrition. Access and system barriers persist. The Dietitians of European Crohn's and Colitis Organisation propose a six‐step plan to formalise and expand the IBD dietitian role.
Alice S. Day, Julie Vanderstappen, Alicia Sandall, Vaios Svolos, Chen Sarbagili Shabat   +4 more
wiley   +1 more source

Mesalamine-induced myocarditis following diagnosis of Crohn's disease: A case report

Revista Portuguesa de Cardiologia, 2013
Mesalamine is a common treatment for Crohn's disease, and can be rarely associated with myocarditis through a mechanism of drug hypersensitivity. We present the case of a 19-year-old male who developed chest pain two weeks after beginning mesalamine ...
Carlos Galvão Braga, Juliana Martins, Carina Arantes, Vítor Ramos, Catarina Vieira, Alberto Salgado, Sónia Magalhães, Adelino Correia   +7 more
doaj   +1 more source

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 1, Page 60-69, January 2026.
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Sohail Aziz, Maria Giovanna Puoti, Amit Assa, Zrinjka Misak, Emmanuel Mas, Osvaldo Borrelli, Jernej Dolinšek, Javier Martin‐de‐Carpi, Isabelle Scheers, Christos Tzivinikos, Matjaž Homan, Caterina Strisciuglio   +11 more
wiley   +1 more source

A novel pH–enzyme-dependent mesalamine colon-specific delivery system

Drug Design, Development and Therapy, 2016
Lei Jin, Yi-cun Ding, Yu Zhang, Xiao-qing Xu, Qin Cao Department of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China Abstract: The aim of the present study was to ...
Jin L, Ding Y, Zhang Y, Xu X, Cao Q
doaj